ETF Holdings Breakdown of EDIT

Stock NameEditas Medicine Inc
TickerEDIT(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS28106W1036
LEI5299000AON4Q9NT2JE42

News associated with EDIT

Invesco Ltd. Has $127,000 Stake in Editas Medicine, Inc. (NASDAQ:EDIT)
Invesco Ltd. increased its stake in Editas Medicine, Inc. (NASDAQ:EDIT – Free Report) by 9.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 100,164 shares of the company’s stock after acquiring an additional 8,448 shares during the quarter. Invesco Ltd.’s […] - 2025-05-06 07:28:46
Editas Medicine (NASDAQ:EDIT) Upgraded at HC Wainwright
HC Wainwright upgraded shares of Editas Medicine (NASDAQ:EDIT – Free Report) to a strong-buy rating in a research report sent to investors on Monday, MarketBeat Ratings reports. The brokerage currently has $3.00 price objective on the stock. Editas Medicine Stock Up 6.5 % Shares of EDIT stock opened at $1.65 on Monday. The firm has […] - 2025-05-01 07:40:50
Cantor Fitzgerald Upgrades Editas Medicine (NASDAQ:EDIT) to Strong-Buy
Editas Medicine (NASDAQ:EDIT – Get Free Report) was upgraded by Cantor Fitzgerald from a “hold” rating to a “strong-buy” rating in a research report issued on Tuesday,Zacks.com reports. Separately, HC Wainwright initiated coverage on Editas Medicine in a research report on Monday. They set a “buy” rating and a $3.00 price objective for the company. […] - 2025-05-01 05:38:48
XTX Topco Ltd Purchases 52,498 Shares of Editas Medicine, Inc. (NASDAQ:EDIT)
XTX Topco Ltd boosted its position in shares of Editas Medicine, Inc. (NASDAQ:EDIT – Free Report) by 99.9% during the 4th quarter, HoldingsChannel.com reports. The firm owned 105,056 shares of the company’s stock after acquiring an additional 52,498 shares during the quarter. XTX Topco Ltd’s holdings in Editas Medicine were worth $133,000 at the end […] - 2025-04-30 08:22:59
Raymond James Financial Inc. Takes Position in Editas Medicine, Inc. (NASDAQ:EDIT)
Raymond James Financial Inc. purchased a new position in shares of Editas Medicine, Inc. (NASDAQ:EDIT – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 238,967 shares of the company’s stock, valued at approximately $303,000. A number of other institutional […] - 2025-04-10 07:14:58
Editas Medicine, Inc. (NASDAQ:EDIT) Receives Average Rating of “Hold” from Brokerages
Editas Medicine, Inc. (NASDAQ:EDIT – Get Free Report) has been given an average rating of “Hold” by the fourteen analysts that are currently covering the stock, MarketBeat reports. Two investment analysts have rated the stock with a sell recommendation, nine have given a hold recommendation and three have issued a buy recommendation on the company. […] - 2025-03-12 06:56:52
Ieq Capital LLC Makes New Investment in Editas Medicine, Inc. (NASDAQ:EDIT)
Ieq Capital LLC acquired a new stake in shares of Editas Medicine, Inc. (NASDAQ:EDIT – Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 24,634 shares of the company’s stock, valued at approximately $31,000. A number of other institutional […] - 2025-03-03 08:50:57
Analysts Set Editas Medicine, Inc. (NASDAQ:EDIT) Price Target at $7.00
Shares of Editas Medicine, Inc. (NASDAQ:EDIT – Get Free Report) have received a consensus rating of “Hold” from the fourteen brokerages that are currently covering the firm, MarketBeat reports. Two equities research analysts have rated the stock with a sell recommendation, nine have assigned a hold recommendation and three have issued a buy recommendation on […] - 2025-02-18 06:44:58

EDIT institutional holdings

The following institutional investment holdings of EDIT have been identified

Date ETF ISIN/Name Num Shares Book value
2024-11-22 IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc)) 38,987USD 95,128 2.9%
2024-11-22 IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc) 29,001USD 70,762 2.9%
2025-05-08 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 38,328USD 53,276 4.3%
2025-05-08 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 38,328USD 53,276 4.3%
2024-11-12 IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc)) 1,933USD 5,934
Total =146,577 USD 278,376
Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.